Pasi Janne, MD, PhD

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 2
- CONDITIONS3
- INTERVENTIONS3
- SINCE2007

A Study of XL184 With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
December 2007 - July 2011

IPI-504 in NSCLC Patients With ALK Translocations
October 2010 - October 2012
Lung Neoplasms
Carcinoma
Carcinoma, Non-Small-Cell Lung
Erlotinib
Xl184
Ipi-504



